11 results on '"C. Pintor"'
Search Results
2. The growth hormone-releasing activity of hexarelin, a new synthetic hexapeptide, in short normal and obese children and in hypopituitary subjects.
- Author
-
Loche S, Cambiaso P, Carta D, Setzu S, Imbimbo BP, Borrelli P, Pintor C, and Cappa M
- Subjects
- Child, Child, Preschool, Female, Growth Hormone-Releasing Hormone pharmacology, Growth Substances pharmacology, Humans, Hydrocortisone blood, Male, Prolactin blood, Puberty, Reference Values, Body Height drug effects, Growth Hormone metabolism, Hypopituitarism metabolism, Obesity metabolism, Oligopeptides pharmacology
- Abstract
Hexarelin (Hex) is a new synthetic hexapeptide with potent growth hormone (GH)-releasing activity in both animals and men. We evaluated the GH response to a maximal dose of Hex (2 micrograms/kg iv) and GH-releasing hormone (GHRH) (1-29, 1 microgram/kg iv) in 45 short normal children (24 males and 21 females, age 5.9-14 yr, 24 prepubertal and 21 in Tanner stage 2 or 3 of pubertal maturation), in 10 prepubertal obese children (7 males and 3 females, age 7.5-12 yr), and in 5 subjects with organic hypopituitarism (4 males and 1 female, age 8.4-21 yr). In 5 male subjects with constitutional growth delay (age 12.0-13.7 yr), the GH response to Hex was reevaluated 1 week after priming with testosterone enanthate (100 mg im). In all short normal children Hex caused a prompt and clear-cut increase of serum GH concentrations, with peaks occurring between 15-30 min from injection. The GH response to Hex was significantly higher than that observed after GHRH and was not different between males and females or between prepubertal and pubertal subjects. Priming with testosterone resulted in an increased GH response to Hex in all 5 subjects studied. No GH increase was observed in the hypopituitary subjects after either GHRH or Hex administration. In the obese children the GH responses to GHRH and to Hex were significantly lower than in the prepubertal children. Also, in the obese, the GH response to Hex was significantly higher than that observed after GHRH. In all short normal and obese children, but not in the hypopituitary subjects, Hex administration caused a slight but significant increase from baseline of both cortisol and PRL concentrations that returned to the baseline values within 2 h. None of the subjects experienced adverse side effects after Hex administration. This study shows that, in short normal and obese children, Hex is a potent GH-releasing stimulus with potential clinical utility.
- Published
- 1995
- Full Text
- View/download PDF
3. Secretion of growth hormone releasing hormone in obese children.
- Author
-
Loche S, Balzano S, Bozzola M, Moretta A, Pintus S, Faedda A, Muntoni A, Carta D, and Pintor C
- Subjects
- Child, Female, Growth Hormone blood, Humans, Levodopa, Male, Growth Hormone-Releasing Hormone metabolism, Obesity physiopathology
- Abstract
We have evaluated baseline and l-dopa-stimulated peripheral growth hormone releasing hormone (pGHRH) secretion in 6 obese pre-pubertal children and in 7 age-matched controls. Baseline pGHRH levels were no different between obese (36.6 +/- 9.8 pg/ml, mean +/- SE) and control children (40.6 +/- 10.1 pg/ml). Administration of l-dopa (500 mg po) caused a significant increase of pGHRH levels in both the obese (65.3 +/- 19.8 pg/ml, p less than 0.05) and the control children (84.1 +/- 10.0 pg/ml, p less than 0.003). Mean peak pGHRH levels after l-dopa were not significantly different between the two groups, whereas mean peak GH levels were significantly lower (p less than 0.05) in the obese (7.9 +/- 1.9 ng/ml) than in the control children (20.5 +/- 4.9 ng/ml). We conclude that despite reduced GH secretion, obese children have normal baseline and l-dopa stimulated pGHRH levels.
- Published
- 1992
- Full Text
- View/download PDF
4. The effect of atenolol on the growth hormone response to growth hormone-releasing hormone in obese children.
- Author
-
Loche S, Pintus S, Carta D, Muntoni AC, Congiu G, Civolani P, and Pintor C
- Subjects
- Child, Child, Preschool, Female, Humans, Kinetics, Male, Receptors, Adrenergic, beta physiology, Atenolol pharmacology, Growth Hormone metabolism, Growth Hormone-Releasing Hormone pharmacology, Obesity physiopathology
- Abstract
We have evaluated the effect of acute administration of atenolol, a selective beta-adrenergic antagonist, on the GH response to GHRH in nine obese children and in eight age-matched controls. The GH response to GHRH (1-29, 1 microgram/kg iv), evaluated both as the GH peak and as integrated area under the curve, was significantly lower in the obese children than in the controls. Pretreatment with atenolol (50 or 100 mg orally in subjects with body weight less than or greater than 40 kg, respectively, administered 120 min before the GHRH injection) significantly increased the GH response to GHRH in the obese subjects, such that their mean peak GH levels and mean integrated area under the curve after atenolol plus GHRH were similar to those of the control children after GHRH. Also in control children, atenolol caused a significant augmentation of the GH response to GHRH. Mean peak GH levels and mean integrated area under the curve after atenolol plus GHRH were significantly higher in the controls than in the obese children given the same treatment. These data show that inhibition of central beta-adrenergic receptors counteracts the blunted GH response to GHRH present in the obese children. In view of the alleged mechanism of action of beta-adrenergic blockade (inhibition of endogenous SRIH release), our data suggest that the somatostatinergic system is intact in obesity, and that the suppressed GH secretion is due to other causes.
- Published
- 1992
- Full Text
- View/download PDF
5. The effect of galanin on baseline and GHRH-induced growth hormone secretion in obese children.
- Author
-
Loche S, Pintus S, Cella SG, Boghen M, Vannelli S, Benso L, Müller EE, Corda R, and Pintor C
- Subjects
- Child, Drug Synergism, Female, Galanin, Growth Hormone blood, Humans, Male, Neuropeptides physiology, Peptides physiology, Growth Hormone metabolism, Growth Hormone-Releasing Hormone pharmacology, Neuropeptides pharmacology, Obesity metabolism, Peptides pharmacology
- Abstract
We have evaluated the effect of the administration of galanin (Gal), a newly identified hypothalamic peptide, on baseline and GHRH-induced GH rise in five obese children and in seven controls. The GH response to GHRH (hpGRF(1-29), 1 microgram/kg i.v.), and to Gal (15 micrograms/kg/h for 1 h), evaluated both as the maximum GH peak and as integrated area under the curve (AUC), was significantly lower in the obese children than in the controls. Simultaneous administration of Gal plus GHRH significantly increased the GH response to GHRH in all the obese subjects, so that their mean peak GH levels and AUC after Gal plus GHRH were similar to those of the control children after GHRH. Also, in control children Gal caused a significant augmentation of the GH response to GHRH. Mean peak GH levels and mean AUC after Gal plus GHRH were significantly higher in the controls than in the obese children given the same treatment. Our data indicate that obese children have a blunted GH response to Gal, which, however, is able to enhance the GH response to GHRH. This observation strengthens the view that the mechanism of action of Gal involves modulation of endogenous somatostatin (SRIH) release. In addition, similarity between the effects of Gal and pyridostigmine on baseline and GHRH-stimulated GH release in obese children may indicate the existence of a cholinergic link in the action of Gal.
- Published
- 1990
- Full Text
- View/download PDF
6. Plasma levels of gonadotropins, prolactin, thyroxine, and adrenal and gonadal steroids in obese prepubertal girls.
- Author
-
Genazzani AR, Pintor C, and Corda R
- Subjects
- Aging, Child, Dehydroepiandrosterone blood, Estradiol blood, Female, Follicle Stimulating Hormone blood, Humans, Pregnenolone blood, Progesterone blood, Prolactin blood, Sexual Maturation, Adrenal Cortex Hormones blood, Gonadal Steroid Hormones blood, Gonadotropins, Pituitary blood, Obesity blood, Thyroxine blood
- Abstract
Plasma levels of gonadotropins, PRL, T4, and adrenal and gonadal steroids were measured in two groups of 7- to 9-yr-old and 10- to 11-yr-old obese prepubertal girls, and were compared to those found in groups of nonobese girls of the same age. The data found in normal weight subjects confirm the data reported in the literature, showing a significant rise between the 7- to 9- and 10- to 11-yr groups, of FSH, pregnenolone, dehydroepiandrosterone, testosterone, and estradiol plasma levels, while LH, PRL, T4, cortisol, progesterone, 17-hydroxyprogesterone (17P), and androstenedione remained constant. In the obese subjects, pregnenolone and dehydroepiandrosterone levels are notably higher than in the normal girls, in the same range as those found in adult women; furthermore, they show no rise between the two age groups. The obese prepubertal groups had significantly higher progesterone, androstenedione, and PRL levels in comparison with those observed in girls of normal weight, but 17-hydroxyprogesterone, cortisol, testosterone, LH, and T4 were similar in both groups. Estradiol levels were markedly depressed in the obese girls; FSH levels were higher in the younger girls than in normal subjects. These data indicate that in prepubertal obesity, maturation of adrenal gland function (chiefly the delta 5 pathway), is notably enhanced, whereas gonadal secretion of estradiol is impaired in the presence of high levels of FSH and PRL.
- Published
- 1978
- Full Text
- View/download PDF
7. Hyperendorphinemia in obese children and adolescents.
- Author
-
Genazzani AR, Facchinetti F, Petraglia F, Pintor C, and Corda R
- Subjects
- Adolescent, Age Factors, Blood Glucose analysis, Child, Child, Preschool, Female, Humans, Hydrocortisone blood, Insulin, Male, Puberty, Reference Values, beta-Endorphin, Endorphins blood, Obesity blood, beta-Lipotropin blood
- Abstract
To study the role of opioid peptides in human obesity, plasma beta-endorphin (beta EP), beta-lipotropin (beta LPH), and cortisol resting values, circadian rhythms, and responses to hypoglycemia were studied in 6 prepubertal and 6 pubertal obese adolescents (at least 40% above ideal body weight) and in 10 normal subjects matched for age, sex, and pubertal development. Baseline plasma beta LPH and beta EP concentrations in both obese children and adolescents were twice as high as those in normal controls, while cortisol levels were not different. Cortisol, beta EP, and beta LPH levels had a clear circadian rhythmicity in all subjects, with the exception of obese pubertal boys whose plasma beta EP concentrations were constant throughout the day. After insulin administration, the fall in blood sugar was similar in all groups. Plasma cortisol and beta EP responses were similar in both obese and normal prepubertal subjects. In obese pubertal adolescents, beta EP did not increase significantly after hypoglycemia, although it did increase in normal weight pubertal subjects. In normal prepubertal subjects, the circadian rhythms of beta EP and beta LPH secretion and release induced by hypoglycemia suggest the presence of a well developed neuroendocrine control of proopiomelanocortin-related peptide secretion. In prepubertal obese children, the increased plasma beta EP and beta LPH levels with the maintenance of their circadian rhythm and responsivity to hypoglycemia suggest overactivity of anterior pituitary secretion. In obese adolescents, in spite of the normal rhythm of beta LPH and cortisol, beta EP levels did not change throughout the day, thus suggesting beta EP secretion from nonpituitary sources in these subjects. The present study indicates a possible direct role for hyperendorphinemia in the induction of overeating in obese children and adolescents.
- Published
- 1986
- Full Text
- View/download PDF
8. Pyridostigmine counteracts the blunted growth hormone response to growth hormone-releasing hormone of obese children.
- Author
-
Loche S, Pintor C, Cappa M, Ghigo E, Puggioni R, Locatelli V, and Müller EE
- Subjects
- Adolescent, Child, Child, Preschool, Growth Hormone blood, Humans, Insulin-Like Growth Factor I blood, Obesity blood, Obesity, Morbid blood, Receptors, Cholinergic drug effects, Growth Hormone metabolism, Growth Hormone-Releasing Hormone administration & dosage, Obesity physiopathology, Obesity, Morbid physiopathology, Pyridostigmine Bromide administration & dosage
- Abstract
We have evaluated the effect of acute administration of pyridostigmine bromide, a cholinesterase inhibitor, on the GHRH-induced GH rise in 11 obese children and in 8 age-matched controls. The GH response to GHRH (hpGRF 1-40, 1 microgram/kg iv), evaluated both as maximum GH peak and as integrated area under the curve, was significantly lower in the obese children than in the controls. Pretreatment with pyridostigmine bromide (60 mg orally 60 min before the GHRH injection) significantly increased both baseline GH levels and the GH response to GHRH in all the obese subjects, so that their mean baseline GH, peak GH levels and integrated area under the curve after pyridostigmine bromide plus GHRH were similar to those of the control children after GHRH. Also in control children pyridostigmine bromide increased (though not significantly) baseline GH levels. and caused a significant augmentation of the GH response to GHRH. Mean peak GH levels and mean integrated area under the curve after pyridostigmine bromide plus GHRH were significantly higher in the controls than in the obese children given the same treatment. Mean baseline Sm-C levels were significantly higher in the obese than in control children. These data show that enhancement of cholinergic neurotransmission, likely in the hypothalamus, counteracts the blunted GH response to GHRH present in the obese children, and that in simple obesity the potential of the pituitary to make a secretory response to a direct GH secretagogue is preserved.
- Published
- 1989
- Full Text
- View/download PDF
9. Adrenal androgens in obese boys before and after weight loss.
- Author
-
Pintor C, Loche S, Faedda A, Fanni V, Nurchi AM, and Corda R
- Subjects
- 17-alpha-Hydroxyprogesterone, Androgens blood, Androstenedione blood, Child, Dehydroepiandrosterone blood, Estradiol blood, Humans, Hydrocortisone blood, Hydroxyprogesterones blood, Male, Obesity diet therapy, Pregnenolone blood, Progesterone blood, Testosterone blood, Adrenal Glands metabolism, Androgens metabolism, Body Weight, Obesity metabolism
- Abstract
The adrenal steroid secretion was studied in 6 prepubertal obese boys and 6 obese boys at the first stage of sexual maturation according to Tanner. Twelve normal boys, closely matched for age and stage of sexual maturation, were also studied as controls. Pregnenolone and dehydroepiandrosterone plasma levels were found to be significantly (P less than 0.001) higher in both groups when compared with normal boys. All the values, apart from pregnenolone in the prepubertal group, returned to normal after weight loss. Progesterone was found significantly increased (P less than 0.001) in both groups and normal after weight loss. 17-OH-progesterone plasma levels showed no significant difference between the obese and control groups. Androstenedione was increased in the prepubertal group before and normal after weight loss; no significant difference was found in the other group. Testosterone and estradiol showed normal values in the two groups both before and after weight loss. Cortisol showed a similar pattern. It can be concluded that an increased cortico-adrenal activity is present in obese boys as already reported in obese girls. This finding could explain the precocious adrenarche which often occurs in these patients. The increased adrenal androgen secretion might be due to an increased cortico adrenal stimulating hormone secretion or to an enhanced adrenal sensitivity to this hypothetical hormone.
- Published
- 1984
- Full Text
- View/download PDF
10. Reduced growth hormone response to growth hormone-releasing hormone in children with simple obesity: evidence for somatomedin-C mediated inhibition.
- Author
-
Loche S, Cappa M, Borrelli P, Faedda A, Crinò A, Cella SG, Corda R, Müller EE, and Pintor C
- Subjects
- Body Weight, Child, Child, Preschool, Fatty Acids, Nonesterified blood, Feedback, Female, Humans, Insulin blood, Male, Growth Hormone blood, Growth Hormone-Releasing Hormone, Insulin-Like Growth Factor I blood, Obesity physiopathology, Somatomedins blood
- Abstract
We have evaluated the plasma GH response to a single injection of 1 microgram/kg of GH-releasing hormone (GHRH)-40 in 15 obese children and 15 age-matched control children. Most of the obese children showed a subnormal plasma GH response to GHRH and the mean plasma GH integrated area (IC-GH) following stimulation was significantly smaller in obese than control children. Plasma somatomedin-C (SM-C) levels were significantly higher in obese than control children, and were negatively correlated with the peak plasma GH levels (r = -0.616, P less than 0.01) and the IC-GH (r = -0.554, P less than 0.02) after GHRH. Non-esterified fatty acids (NEFA) and fasting plasma insulin levels were also elevated in obese children, but did not correlate with the extent of plasma GH response to GHRH. These data confirm previous observations on the refractoriness of obese children to release GH after GHRH, and imply that it may be due to the feedback inhibition operated by the elevated plasma levels of SM-C.
- Published
- 1987
- Full Text
- View/download PDF
11. Adrenal Androgens in Obese Boys before and after Weight Loss
- Author
-
A. Faedda, C Pintor, S Loche, V. Fanni, A M Nurchi, and R. Corda
- Subjects
Male ,medicine.medical_specialty ,Hydrocortisone ,Endocrinology, Diabetes and Metabolism ,Clinical Biochemistry ,Dehydroepiandrosterone ,Biochemistry ,Endocrinology ,Weight loss ,Internal medicine ,Adrenal Glands ,Hydroxyprogesterones ,medicine ,Humans ,Testosterone ,Obesity ,Androstenedione ,Child ,Progesterone ,Estradiol ,business.industry ,17-alpha-Hydroxyprogesterone ,Adrenarche ,Body Weight ,Biochemistry (medical) ,General Medicine ,Androgen secretion ,Pregnenolone ,Androgens ,medicine.symptom ,business ,medicine.drug ,Hormone - Abstract
The adrenal steroid secretion was studied in 6 prepubertal obese boys and 6 obese boys at the first stage of sexual maturation according to Tanner. Twelve normal boys, closely matched for age and stage of sexual maturation, were also studied as controls. Pregnenolone and dehydroepiandrosterone plasma levels were found to be significantly (P less than 0.001) higher in both groups when compared with normal boys. All the values, apart from pregnenolone in the prepubertal group, returned to normal after weight loss. Progesterone was found significantly increased (P less than 0.001) in both groups and normal after weight loss. 17-OH-progesterone plasma levels showed no significant difference between the obese and control groups. Androstenedione was increased in the prepubertal group before and normal after weight loss; no significant difference was found in the other group. Testosterone and estradiol showed normal values in the two groups both before and after weight loss. Cortisol showed a similar pattern. It can be concluded that an increased cortico-adrenal activity is present in obese boys as already reported in obese girls. This finding could explain the precocious adrenarche which often occurs in these patients. The increased adrenal androgen secretion might be due to an increased cortico adrenal stimulating hormone secretion or to an enhanced adrenal sensitivity to this hypothetical hormone.
- Published
- 1984
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.